• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: HEARTWARE, INC. HEARTWARE VENTRICULAR ASSIST SYSTEM - BATTERY; VENTRICULAR (ASSIST) BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

HEARTWARE, INC. HEARTWARE VENTRICULAR ASSIST SYSTEM - BATTERY; VENTRICULAR (ASSIST) BYPASS Back to Search Results
Model Number 1650
Medical Device Problem Code Battery Problem (2885)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 10/19/2020
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Investigation of this event is pending and a supplemental report will be sent upon its completion.If information is provided in the future, a supplemental report will be issued.
 
Event or Problem Description
It was reported that the battery exhibited an erroneous critical battery alarm.The battery charge was 63% at the time of the alarm.Multiple power disconnect alarms were also noted.The battery was exchanged.No patient complications have been reported as a result of this event.
 
Additional Manufacturer Narrative
A supplemental report is being submitted for device evaluation product event summary: the battery was returned for investigation.Various analyses were conducted and reviewed in order to evaluate the performance of the device in relation to the reported event.Failure analysis of the returned device revealed that the battery passed visual inspection and functional testing.The available autologs report revealed that a critical battery alarm involving a battery was logged on (b)(6) 2020 with a battery capacity above 10% relative state of charge (rsoc).Additionally, the autologs report revealed that multiple power disconnect alarms were logged involving a battery since (b)(6) 2020.As a result, the reported critical battery alarm and power disconnect alarm events were confirmed.However, raw controller log files were not available for analysis.As a result, the reported communication errors event could not be confirmed.A power source lubrication procedure had been performed on the battery in accordance with the requirements under fsca cvg-18-q4-19 on 28/dec/2018.Applicable risk documentation, experience with events of similar circumstances, and the available information were considered.A possible root cause of the reported power disconnect alarm event can be attributed, but not limited, to a communication error and/or a faulty battery.The most likely root cause of the reported critical battery alarm involving a battery above 10% rsoc event may be attributed to a communication error between the controller and battery.A possible root cause of communication errors can be attributed to momentary disconnections on the communication pins of the controller, the controller not receiving responses from the batteries, and/or due to the packet error checking method detecting bit errors.Investigation of this event is completed, and the file will be closed.If new information is received, the file will be re-opened, and a supplemental will be submitted.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HEARTWARE VENTRICULAR ASSIST SYSTEM - BATTERY
Common Device Name
VENTRICULAR (ASSIST) BYPASS
Manufacturer (Section D)
HEARTWARE, INC.
14400 nw 60th ave
miami lakes FL 33014
MDR Report Key10856846
Report Number3007042319-2020-07350
Device Sequence Number16283397
Product Code DSQ
UDI-Device Identifier00888707002646
UDI-Public00888707002646
Combination Product (Y/N)N
Initial Reporter StateOK
Initial Reporter CountryUS
PMA/510(K) Number
P100047
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Other Health Care Professional
Remedial Action Recall
Type of Report Initial,Followup
Report Date (Section B) 01/05/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Lay User/Patient
Device Expiration Date08/31/2019
Device Model Number1650
Device Catalogue Number1650
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/11/2020
Initial Date Received by Manufacturer 10/30/2020
Supplement Date Received by Manufacturer12/22/2020
Initial Report FDA Received Date11/17/2020
Supplement Report FDA Received Date01/05/2021
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
If action reported to FDA under 21 USC 360i(g), list
FDA-assigned Recall Number or include a statement
Z-1903-2018
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
1103 VAD
Patient Age59 YR
-
-